This study assessed the efficacy of once-daily layered application of a betamethasone butyrate propionate lotion (ANT-L) and a calcipotriol ointment (DOV-O) and the influence of this combination on the quality of life (QOL) of 59 psoriasis vulgaris patients with skin eruptions refractory to a topical treatment with a steroid ointment alone or in combination with an active vitamin D
3 (VD
3) ointment. For analysis, the subjects were stratified according to the previous treatment received. The previous treatment comprised monotherapy with a very strong (VG) or higher-class steroid ointment in 35 patients and combination therapy with a VG or higher-class steroid ointment plus a VD
3 ointment in 24 patients. In both groups, skin symptoms and QOL of the patients significantly improved after the study treatment. The study results indicate that oncedaily topical layered application of the DOV-O/ANT-L combination therapy is efficacious in treating psoriasis vulgaris refractory to a previous topical treatment. The changes in the study treatment from the previous treatment involved a change of the dosage form of the steroid medication from ointment to lotion as well as either addition of or change to DOV-O from a VD
3 ointment. Improved treatment compliance could be a major factor influencing the efficacy of the layered DOVO/ANT-L combination therapy.
View full abstract